By Danny Sullivan – Longevity Technology –
Khosla-backed company aims to double number of longevity clinics offering TPE to consumers seeking health benefits.
Hot on the heels of a human trial that demonstrated its technology lowered biological age, therapeutic plasma exchange (TPE) provider Circulate Health has landed $12 million in seed funding, led by Khosla Ventures. The company’s patented TPE procedure removes, separates and replaces your plasma, with the goal of reducing inflammation and improving healthspan.
